UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Chitosan-poly(lactide-co-glycolide)/poloxamer mixed micelles as a mucoadhesive thermo-responsive moxifloxacin eye drop to improve treatment efficacy in bacterial keratitis

Carbohydrate polymers, 2023-07, Vol.312, p.120822-120822, Article 120822

2023

Volltextzugriff (PDF)

Effects of moxifloxacin and gatifloxacin stress on growth, photosynthesis, antioxidant responses, and microcystin release in Microcystis aeruginosa

Journal of hazardous materials, 2021-05, Vol.409, p.124518-124518, Article 124518

2021

Volltextzugriff (PDF)

Dual Drug-Loaded Coaxial Nanofiber Dressings for the Treatment of Diabetic Foot Ulcer

International journal of nanomedicine, 2024-01, Vol.19, p.5681-5703

2024

Volltextzugriff (PDF)

Prospectively predicting BPaMZ phase IIb/III trial outcomes using a translational mouse-to-human platform

Antimicrobial agents and chemotherapy, 2024-10, Vol.68 (10), p.e0061524

2024

Volltextzugriff (PDF)

Thermochromic Hydrogel-Functionalized Textiles for Synchronous Visual Monitoring of On-Demand In Vitro Drug Release

ACS applied materials & interfaces, 2020-11, Vol.12 (46), p.51225-51235

2020

Volltextzugriff (PDF)

Moxifloxacin-Mediated Killing of Mycobacterium tuberculosis Involves Respiratory Downshift, Reductive Stress, and Accumulation of Reactive Oxygen Species

Antimicrobial agents and chemotherapy, 2022-09, Vol.66 (9), p.e0059222-e0059222

2022

Volltextzugriff (PDF)

Bedaquiline containing triple combination powder for inhalation to treat drug-resistant tuberculosis

International journal of pharmaceutics, 2019-10, Vol.570, p.118689, Article 118689

2019

Volltextzugriff (PDF)

Omadacycline Pharmacokinetics/Pharmacodynamics in the Hollow Fiber System Model and Potential Combination Regimen for Short Course Treatment of Mycobacterium kansasii Pulmonary Disease

Antimicrobial agents and chemotherapy, 2022-09, Vol.66 (9), p.e0068722

2022

Volltextzugriff (PDF)

Investigating the treatment shortening potential of a combination of bedaquiline, delamanid and moxifloxacin with and without sutezolid, in a murine tuberculosis model with confirmed drug exposures

Journal of antimicrobial chemotherapy, 2024-10, Vol.79 (10), p.2607-2610

2024

Volltextzugriff (PDF)

Combination Therapy to Kill Mycobacterium tuberculosis in Its Nonreplicating Persister Phenotype

Antimicrobial agents and chemotherapy, 2022-10, Vol.66 (10), p.e0069522

2022

Volltextzugriff (PDF)

Ciprofloxacin and moxifloxacin could interact with SARS-CoV-2 protease: preliminary in silico analysis

Pharmacological reports, 2020-12, Vol.72 (6), p.1553-1561

2020

Volltextzugriff (PDF)

Mechanistic and biophysical insight into the inhibitory and disaggregase role of antibiotic moxifloxacin on human lysozyme amyloid formation

Biophysical chemistry, 2023-07, Vol.298, p.107029-107029, Article 107029

2023

Volltextzugriff (PDF)

Combination Therapy for Mycoplasma genitalium, and New Insights Into the Utility of parC Mutant Detection to Improve Cure

Clinical infectious diseases, 2022-09, Vol.75 (5), p.813-823

2022

Volltextzugriff (PDF)

Anticancer activity and metabolic alteration in colon and prostate cancer cells by novel moxifloxacin conjugates with fatty acids

European journal of pharmacology, 2023-02, Vol.940, p.175481, Article 175481

2023

Volltextzugriff (PDF)

Arabic gum plus colistin coated moxifloxacin-loaded nanoparticles for the treatment of bone infection caused by Escherichia coli

Acta biomaterialia, 2022-01, Vol.137, p.218-237

2022

Volltextzugriff (PDF)

Gellan Gum-Based Bilayer Mucoadhesive Films Loaded with Moxifloxacin Hydrochloride and Clove Oil for Possible Treatment of Periodontitis

Drug design, development and therapy, 2021-01, Vol.15, p.3937-3952

2021

Volltextzugriff (PDF)

Mutations in ParC and GyrA of moxifloxacin-resistant and susceptible Mycoplasma genitalium strains

PloS one, 2018-06, Vol.13 (6), p.e0198355-e0198355

2018

Volltextzugriff (PDF)

Moxifloxacin-isatin Hybrids Tethered by 1,2,3-triazole and their Anticancer Activities

Current topics in medicinal chemistry, 2020-01, Vol.20 (16), p.1461-1467

2020

Volltextzugriff (PDF)

Moxifloxacin-loaded nanoparticles of thiolated xyloglucan for ocular drug delivery: Permeation, mucoadhesion and pharmacokinetic evaluation

International journal of biological macromolecules, 2024-06, Vol.270 (Pt 2), p.132522-132522, Article 132522

2024

Volltextzugriff (PDF)

What Is Resistance? Impact of Phenotypic versus Molecular Drug Resistance Testing on Therapy for Multi- and Extensively Drug-Resistant Tuberculosis

Antimicrobial agents and chemotherapy, 2018-02, Vol.62 (2), p.e01550

2018

Volltextzugriff (PDF)

Extracellular vesicles deliver Mycobacterium RNA to promote host immunity and bacterial killing

EMBO reports, 2019-03, Vol.20 (3), p.n/a

2019

Volltextzugriff (PDF)

Effect of Moxifloxacin plus Pretomanid against Mycobacterium tuberculosis in Log Phase, Acid Phase, and Nonreplicating-Persister Phase in an In Vitro Assay

Antimicrobial agents and chemotherapy, 2019-01, Vol.63 (1)

2019

Volltextzugriff (PDF)

The Mycobacterial Efflux Pump EfpA Can Induce High Drug Tolerance to Many Antituberculosis Drugs, Including Moxifloxacin, in Mycobacterium smegmatis

Antimicrobial agents and chemotherapy, 2021-10, Vol.65 (11), p.e0026221-e0026221

2021

Volltextzugriff (PDF)

Thermoresponsive GenisteinNLC-dexamethasone-moxifloxacin multi drug delivery system in lens capsule bag to prevent complications after cataract surgery

Scientific reports, 2021-01, Vol.11 (1), p.181-13, Article 181

2021

Volltextzugriff (PDF)

1 – 25 von 1.553

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.508)
Mit Volltextzugriff
(1.344)

Publikationsform

Artikel
(1.545)
Buchkapitel
(8)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.474)
Life Sciences & Biomedicine
(1.407)
Moxifloxacin
(1.403)
Pharmacology & Pharmacy
(968)
Humans
(939)
Fluoroquinolones
(708)
Microbiology
(536)
Infectious Diseases
(492)
Biological And Medical Sciences
(480)
Medical Sciences
(471)
Microbial Sensitivity Tests
(469)
Pharmacology. Drug Treatments
(441)
Male
(439)
Anti-Bacterial Agents - Pharmacology
(417)
Female
(403)
Antibiotics
(370)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(351)
Antibacterial Agents
(295)
Adult
(294)
Levofloxacin
(275)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(1.268)
EZB-FREE-00999 freely available EZB journals
(812)
IngentaConnect
(681)
Journals@Ovid
(541)
IngentaConnect Journals
(307)
Access via ScienceDirect (Elsevier)
(285)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(222)
Access via Wiley Online Library
(200)
SpringerNature Journals
(179)
Single Journals
(178)
Wiley Online Library Full Collection 2018
(160)
Access via Taylor & Francis
(139)
Access via Oxford University Press
(134)
Oxford Journals 2020 Medicine
(124)
EZB-NALI2-00462 Springer Archive NL
(102)
Taylor & Francis Current Content Access
(93)
Access via Taylor & Francis
(82)
Nexis Uni
(44)
JSTOR
(24)
Nature
(24)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Chitosan-poly(lactide-co-glycolide)/poloxamer mixed micelles as a mucoadhesive thermo-responsive moxifloxacin eye drop to improve treatment efficacy in bacterial keratitis

Effects of moxifloxacin and gatifloxacin stress on growth, photosynthesis, antioxidant responses, and microcystin release in Microcystis aeruginosa

Dual Drug-Loaded Coaxial Nanofiber Dressings for the Treatment of Diabetic Foot Ulcer

Prospectively predicting BPaMZ phase IIb/III trial outcomes using a translational mouse-to-human platform

Thermochromic Hydrogel-Functionalized Textiles for Synchronous Visual Monitoring of On-Demand In Vitro Drug Release

Moxifloxacin-Mediated Killing of Mycobacterium tuberculosis Involves Respiratory Downshift, Reductive Stress, and Accumulation of Reactive Oxygen Species

Bedaquiline containing triple combination powder for inhalation to treat drug-resistant tuberculosis

Omadacycline Pharmacokinetics/Pharmacodynamics in the Hollow Fiber System Model and Potential Combination Regimen for Short Course Treatment of Mycobacterium kansasii Pulmonary Disease

Investigating the treatment shortening potential of a combination of bedaquiline, delamanid and moxifloxacin with and without sutezolid, in a murine tuberculosis model with confirmed drug exposures

Combination Therapy to Kill Mycobacterium tuberculosis in Its Nonreplicating Persister Phenotype

Ciprofloxacin and moxifloxacin could interact with SARS-CoV-2 protease: preliminary in silico analysis

Mechanistic and biophysical insight into the inhibitory and disaggregase role of antibiotic moxifloxacin on human lysozyme amyloid formation

Combination Therapy for Mycoplasma genitalium, and New Insights Into the Utility of parC Mutant Detection to Improve Cure

Anticancer activity and metabolic alteration in colon and prostate cancer cells by novel moxifloxacin conjugates with fatty acids

Arabic gum plus colistin coated moxifloxacin-loaded nanoparticles for the treatment of bone infection caused by Escherichia coli

Gellan Gum-Based Bilayer Mucoadhesive Films Loaded with Moxifloxacin Hydrochloride and Clove Oil for Possible Treatment of Periodontitis

Mutations in ParC and GyrA of moxifloxacin-resistant and susceptible Mycoplasma genitalium strains

Moxifloxacin-isatin Hybrids Tethered by 1,2,3-triazole and their Anticancer Activities

Towards clinical breakpoints for non-tuberculous mycobacteria – Determination of epidemiological cut off values for the Mycobacterium avium complex and Mycobacterium abscessus using broth microdilution

Moxifloxacin-loaded nanoparticles of thiolated xyloglucan for ocular drug delivery: Permeation, mucoadhesion and pharmacokinetic evaluation

What Is Resistance? Impact of Phenotypic versus Molecular Drug Resistance Testing on Therapy for Multi- and Extensively Drug-Resistant Tuberculosis

Extracellular vesicles deliver Mycobacterium RNA to promote host immunity and bacterial killing

Effect of Moxifloxacin plus Pretomanid against Mycobacterium tuberculosis in Log Phase, Acid Phase, and Nonreplicating-Persister Phase in an In Vitro Assay

The Mycobacterial Efflux Pump EfpA Can Induce High Drug Tolerance to Many Antituberculosis Drugs, Including Moxifloxacin, in Mycobacterium smegmatis

Thermoresponsive GenisteinNLC-dexamethasone-moxifloxacin multi drug delivery system in lens capsule bag to prevent complications after cataract surgery

Suchergebnisse filtern